Asia Pacific Digital Therapeutics Market Size & Forecast, 2027

Asia Pacific Digital Therapeutics Market By End Use (Patients, Providers, Payers, Employers and Others), By Applications (Diabetes, CNS Disease, Respiratory Diseases, Smoking Cessation, Obesity, CVD and others), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

Published Date: May-2021 | Number of Pages: 83 | Format: PDF | Report ID: KBV-14764

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Digital Therapeutics Market, by End Use
1.4.2 Asia Pacific Digital Therapeutics Market, by Application
1.4.3 Asia Pacific Digital Therapeutics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Restraints:

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Business Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Mar – 2021, Mar) Leading Players

Chapter 4. Asia Pacific Digital Therapeutics Market by End Use
4.1 Asia Pacific Patients Market by Country
4.2 Asia Pacific Providers Market by Country
4.3 Asia Pacific Payers Market by Country
4.4 Asia Pacific Employers Market by Country
4.5 Asia Pacific Other End Use Market by Country

Chapter 5. Asia Pacific Digital Therapeutics Market by Applications
5.1 Asia Pacific Diabetes Applications Market by Country
5.2 Asia Pacific CNS Disease Applications Market by Country
5.3 Asia Pacific Respiratory Diseases Applications Market by Country
5.4 Asia Pacific Smoking Cessation Applications Market by Country
5.5 Asia Pacific Obesity Applications Market by Country
5.6 Asia Pacific CVD Applications Market by Country
5.7 Asia Pacific Other Applications Market by Country

Chapter 6. Asia Pacific Digital Therapeutics Market by Country
6.1 China Digital Therapeutics Market
6.1.1 China Digital Therapeutics Market by End Use
6.1.2 China Digital Therapeutics Market by Applications
6.2 Japan Digital Therapeutics Market
6.2.1 Japan Digital Therapeutics Market by End Use
6.2.2 Japan Digital Therapeutics Market by Applications
6.3 India Digital Therapeutics Market
6.3.1 India Digital Therapeutics Market by End Use
6.3.2 India Digital Therapeutics Market by Applications
6.4 South Korea Digital Therapeutics Market
6.4.1 South Korea Digital Therapeutics Market by End Use
6.4.2 South Korea Digital Therapeutics Market by Applications
6.5 Singapore Digital Therapeutics Market
6.5.1 Singapore Digital Therapeutics Market by End Use
6.5.2 Singapore Digital Therapeutics Market by Applications
6.6 Malaysia Digital Therapeutics Market
6.6.1 Malaysia Digital Therapeutics Market by End Use
6.6.2 Malaysia Digital Therapeutics Market by Applications
6.7 Rest of Asia Pacific Digital Therapeutics Market
6.7.1 Rest of Asia Pacific Digital Therapeutics Market by End Use
6.7.2 Rest of Asia Pacific Digital Therapeutics Market by Applications

Chapter 7. Company Profiles
7.1 ResMed, Inc. (Propeller Health)
7.1.1 Company Overview
7.1.1 Financial Analysis
7.1.2 Segmental and Regional Analysis
7.1.3 Research & Development Expense
7.1.4 Recent strategies and developments:
7.1.4.1 Approvals and Trials:
7.1.4.2 Partnerships, Collaborations, and Agreements:
7.2 Teladoc Health, Inc. (Livongo Health)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Recent strategies and developments:
7.2.3.1 Partnerships, Collaborations, and Agreements:
7.2.3.2 Acquisition and Mergers:
7.3 Noom, Inc.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations, and Agreements:
7.4 Omada Health, Inc.
7.4.1 Company Overview
7.4.2 Recent strategies and developments:
7.4.2.1 Partnerships, Collaborations, and Agreements:
7.4.2.2 Acquisition and Mergers:
7.4.2.3 Product Launches and Product Expansions:
7.5 Welldoc, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Canary Health
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Partnerships, Collaborations, and Agreements:
7.6.2.2 Business Expansions:
7.7 Mango Health, Inc. (TrialCard, Incorporated)
7.7.1 Company Overview
7.7.2 Recent strategies and developments:
7.7.2.1 Partnerships, Collaborations, and Agreements:
7.8 2Morrow, Inc.
7.8.1 Company Overview
7.9 Pear Therapeutics, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Acquisition and Mergers:
7.9.2.3 Product Launches and Product Expansions:
7.10. Mindstrong, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities